TARA Biosystems Revenue and Competitors
Estimated Revenue & Valuation
- TARA Biosystems's estimated annual revenue is currently $852.5k per year.
- TARA Biosystems's estimated revenue per employee is $77,500
- TARA Biosystems's total funding is $21.3M.
Employee Data
- TARA Biosystems has 11 Employees.
- TARA Biosystems grew their employee count by -27% last year.
TARA Biosystems's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Research Scientist | Reveal Email/Phone |
2 | Product Marketing & Sales Manager | Reveal Email/Phone |
3 | Senior Research Scientist | Reveal Email/Phone |
TARA Biosystems Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is TARA Biosystems?
TARA is dedicated to pioneering predictive cardiac tissue models that enable faster, safer, and more reliable development of new medicines. Safer and more effective new medicines that rapidly make it to market means better health and longer life, and we believe that's great for people everywhere. TARA is focused on three critical areas. Cardiac Toxicology: TARA's predictive tissue-based cardiac model behaves like a human heart muscle. This means that when it is employed in drug testing it can reliably identify cardiovascular complications where cell culture and animal testing models cannot; leading to a faster, safer, and less costly development process. Precision Cardiology: Every person is different and each person's biology contains information particular only to them. TARA's platform can be used to create custom cardiac models tailored to a single person, allowing for personalized health and treatment. Heart Failure Drug Discovery: Heart failure remains a leading cause of death throughout the world. TARA's platform generates physiologically accurate diseased human tissue from stem cells; allowing for reliable testing of medicines created to treat specific heart conditions. Visit us http://tarabiosystems.com or contact us at info@tarabiosystems.com!
keywords:N/A
$21.3M
Total Funding
11
Number of Employees
$852.5k
Revenue (est)
-27%
Employee Growth %
N/A
Valuation
N/A
Accelerator
TARA Biosystems News
To help boost its drug discovery and development work in cardiovascular disease, Valo Health is acquiring TARA Biosystems, makers of a 3D...
Headquartered in New York City, TARA Biosystems harnesses innovations in stem cell biology and tissue engineering to generate in vitro biology...
Valo Health has acquired 180 Degree Capital's (TURN +0.7%) private portfolio company, Tara Biosystems. Under the terms of the acquisition,...
Tara Biosystems, Inc., a NYC-based vitro human biology company, raised $10m in Series A2 financing. Backers included new investors OMX Ventures, Merieux Equity Partners, and LifeForce Capital and current investors Alexandria Venture Investments, Partnership Fund for New York City, Trancos Ventu ...
NEW YORK--(BUSINESS WIRE)--TARA Biosystems, Inc., a company generating in vitro human biology to increase the success of cardiac disease drug discovery and development, today announced a $10 million Series A2 financing. This financing will be used to scale TARA’s cardiac tissue engineering platf ...
Other Companies in NEW YORK
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.9M | 11 | -15% | $3M |
#2 | $0.3M | 11 | -8% | $13.7M |
#3 | $1M | 11 | -27% | N/A |
#4 | $2.2M | 11 | 0% | N/A |
#5 | $1.1M | 11 | 22% | N/A |